CD274 and neoplasm: A great amount of work has focused on determining whether tumour and/or tumour-infiltrating immune cell protein expression of programmed cell death ligand 1 (PD-L1) could predict response to ICI therapy (11, 13, 15–17), but the results were controversial (18, 19).